MURA Mural Oncology plc: Bozor kapitallashuvining balans qiymatiga nisbati

muraloncology.com (MURA) - korporativ logo

GURU.Markets platformasida Mural Oncology plc (MURA) uchun narxlar dinamikasining vizualizatsiyasi onkologik dori vositalarini ishlab chiqishda ESG ekologik standartlari va bioetikani joriy etishga oid ma'lumotlarni to'ldiradi, bunda ko'rsatkich 0.63 darajasida turibdi. Biznes buyrak o'smalari va melanomaga qarshi kurashish uchun sitokinlarni modifikatsiya qilishga tayanadi. Rivojlanish strategiyasi tuxumdon saratoni davolash paytida immunitetni faollashtirish uchun noyob interleykinlarni (IL-2) yaratishga asoslangan.

Mural Oncology (MURA) - Bozor kapitallashuvining balans qiymatiga nisbati 21.02.2024dan 20.12.2025gacha

MURA (Mural Oncology plc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi muraloncology.com|MURA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Mural Bio|MURA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Mural Oncology|MURA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati muraloncology.com|MURA - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Mural Oncology plc|MURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati muraloncology.com|MURA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Mural Bio|MURA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Mural Oncology
Fundamental baholash:MURA (Mural Oncology PLC)
Mural Oncology plc tayyor mahsulotlari

Yuqori patent kengaytiruvchanligiga ega bo'lgan Mural Oncology (MURA) biofarmatsevtika biznesi uchun bozor narxi va sof aktiv qiymati o'rtasidagi farq investorlarning kelajakdagi foydadan kutganlarini aks ettiradi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini kapitalning balans qiymati bilan solishtiradi. Bozor va balans baholash metrikalari grafigining tahlili kompaniyaning haddan tashqari yuqori baholanganlik darajasini ochib beradi. Indikatorning o'sishi bozorning sitokin dori vositalarining tijorat muvaffaqiyatiga bo'lgan ishonchini tasdiqlaydi, ko'rsatkichning pasayishi esa fundamental aktivlarning past baholanganligidan dalolat beradi.

Asosiy raqobatchilar

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIT|Bozor qiymatining balans qiymatiga nisbati CVM (CEL-SCI Corporation)|Kapitallashuvning sof aktivlarga nisbati ostherapies.com OSTX|Kapitallashuvning sof aktivlarga nisbati RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adlai Nortye Limited (ANL)|VERU - Balans qiymatiga nisbatan bozor qiymati|TPST: Bozor kapitallashuvining balans qiymatiga nisbati|XLO (Xilio Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Renovaro Biosciences|Bozor qiymatining balans qiymatiga nisbati Kairos Pharma Inc (KAPA)|OnKure Therapeutics Inc (OKUR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati GDTC (w2.cytomed.sg)|CRIS: Bozor qiymatining balans qiymatiga nisbati|Apollomics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Tharimmune (THAR) - Bozor qiymatining balans qiymatiga nisbati|ADVB - Kapitallashuvning balans qiymatiga nisbati|GNPX (Genprex, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|CLDI (Calidi Biotherapeutics, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIO|Bozor qiymatining balans qiymatiga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|Bozor qiymatining balans qiymatiga nisbati PPBT (Purple Biotech Ltd)|AONC: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti BeiGene Ltd BGNE|Bozor kapitallashuvining balans qiymatiga nisbati CKPT|Elevation Oncology Inc. (ELEV) - Bozor qiymatining xususiy kapitalga nisbati|Kapitallashuvning sof aktivlarga nisbati ICAD|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology|NTBL - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati VIRX|MOR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi NAYA (nayabiosciences.com)|Bozor qiymatining balans qiymatiga nisbati Ascentage Pharma AAPGV